Erwin De Cock, principal for real world and late phase development at Syneos Health, speaks to pharmaphorum at the eyeforpharma conference in Barcelona about our Biopharmaceutical Acceleration Model and the increasing importance of real-world evidence.
This content was repurposed from pharmaphorum.
